Skip to main content

CITADEL ADVISORS LLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1423053 MIAMI, FL

Position in AVBP

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,833,241
-$5,391,819 QoQ
Shares Held
166,157
-63.8% QoQ
Ownership
0.357%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Derivatives in AVBP

reported options exposure · as of Mar 31, 2026
CallValue
$3,721,191
CallShares
161,300
PutValue
$595,206
PutShares
25,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. AVBP ranks #148 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVBP

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $595,206 25,800
2026-03-31 $3,721,191 161,300
2026-03-31 $3,833,241 166,157
2025-12-31 $9,225,060 458,502
2025-06-30 $732,669 33,655
2024-03-31 $5,117,103 286,512